» Articles » PMID: 17666587

Long-range Activation of GREB1 by Estrogen Receptor Via Three Distal Consensus Estrogen-responsive Elements in Breast Cancer Cells

Overview
Journal Mol Endocrinol
Date 2007 Aug 2
PMID 17666587
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The estrogen receptor (ER) binds to estrogen-responsive elements (EREs) to activate gene transcription. The best characterized EREs are located in proximal gene promoters, but recent data indicate that only a minority of ER binding sites lie within proximal promoter regions. GREB1 (gene regulated by estrogen in breast cancer 1) is an ER target gene that regulates estrogen-induced proliferation in breast cancer cells. We identified three consensus EREs, located at -21.2, -9.5, and -1.6 kb upstream of the closest GREB1a transcription start site that appear to mediate long-range GREB1 gene activation by ER. All three ERE sites nucleate ER, steroid receptor coactivator-3 (SRC-3), and RNA polymerase II (Pol II) and undergo histone acetylation in response to estradiol. Estrogen-stimulated ER binding at all three EREs was cyclic and synchronous. SRC-3 and Pol II recruitment to all three EREs was activated by estrogen but not tamoxifen. In contrast, estrogen stimulated only Pol II and not ER or SRC-3 recruitment to the GREB1 core promoter regions. Long-range histone acetylation, centered on the three ERE motifs and the GREB1 core promoters, was observed in response to estrogen but not to tamoxifen. These data suggest that estrogen-stimulated GREB1 transcription may involve coordinated ER binding to all three distal consensus ERE motifs. Long-range activation by ER acting at multiple EREs may be more common than previously appreciated.

Citing Articles

Enhancer-promoter entanglement explains their transcriptional interdependence.

Panigrahi A, Lonard D, OMalley B Proc Natl Acad Sci U S A. 2023; 120(4):e2216436120.

PMID: 36656865 PMC: 9942820. DOI: 10.1073/pnas.2216436120.


Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation.

Sklias A, Halaburkova A, Vanzan L, Jimenez N, Cuenin C, Bouaoun L Nucleic Acids Res. 2021; 49(17):9738-9754.

PMID: 34403459 PMC: 8464064. DOI: 10.1093/nar/gkab697.


Physiologically Relevant Estrogen Receptor Alpha Pathway Reporters for Single-Cell Imaging-Based Carcinogenic Hazard Assessment of Estrogenic Compounds.

Duijndam B, Goudriaan A, van den Hoorn T, van der Stel W, Le Devedec S, Bouwman P Toxicol Sci. 2021; 181(2):187-198.

PMID: 33769548 PMC: 8163057. DOI: 10.1093/toxsci/kfab037.


Case report: 16-yr life history and genomic evolution of an ER HER2 breast cancer.

Xu B, Amallraja A, Swaminathan P, Elsey R, Davis C, Theel S Cold Spring Harb Mol Case Stud. 2020; 6(6).

PMID: 33008833 PMC: 7784492. DOI: 10.1101/mcs.a005629.


Nuclear Receptors, Ligands and the Mammalian B Cell.

Jones B, Penkert R, Surman S, Sealy R, Hurwitz J Int J Mol Sci. 2020; 21(14).

PMID: 32679815 PMC: 7404052. DOI: 10.3390/ijms21144997.